ArticleCell reports. Medicine2025

Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity.

Liming Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.